 |
|
 |
|
|
Incubated Companies
Fabrus LLC
Fabrus LLC is the first company to enter The Pfizer Incubator and was founded by Vaughn Smider, PhD,
an assistant professor at The Scripps Research Institute. Fabrus LLC is developing a novel technology
platform to enable the identification of unique therapeutic antibodies that might lead to new therapies.
The technology will allow screening for antibodies with functional activity and the company will be
developing novel antibody libraries and ways to screen them against biological targets
Wintherix LLC
Wintherix LLC was founded by a team led by Dr. Dennis Carson, Director of the Moores Cancer
Center and Professor of Medicine at UCSD School of Medicine. The new company will use its proprietary
biological knowledge and Pfizer's compound library to search for molecules that inhibit wnt-related
signaling pathways in cancer cells. Wnt-signaling is thought to play a role in the development of
cancer in humans and represents a potential new way to treat the disease.
RGo Bioscience LLC
RGo Bioscience LLC was co-founded by Dr. Alexander Chucholowski, previously President of
ChemBridge Research Laboratories (CRL), and Dr. Thomas Hermann, an Assistant Professor at the
University of California, San Diego (UCSD), where he researches the potential of small molecules to
act on ribonucleic acid (RNA). RNA plays a key role in many disease mechanisms and the new company
aims to develop novel ways to deliver RNAs into the human body.
|
|
|
|
Home
Contact
FAQ
